Cargando…
Dendrimer-Mediated Delivery of DNA and RNA Vaccines
DNA and RNA vaccines (nucleic acid-based vaccines) are a promising platform for vaccine development. The first mRNA vaccines (Moderna and Pfizer/BioNTech) were approved in 2020, and a DNA vaccine (Zydus Cadila, India), in 2021. They display unique benefits in the current COVID-19 pandemic. Nucleic a...
Autores principales: | Kisakova, Lyubov A., Apartsin, Evgeny K., Nizolenko, Lily F., Karpenko, Larisa I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145063/ https://www.ncbi.nlm.nih.gov/pubmed/37111593 http://dx.doi.org/10.3390/pharmaceutics15041106 |
Ejemplares similares
-
Dendrimers Show Promise for siRNA and microRNA Therapeutics
por: Dzmitruk, Volha, et al.
Publicado: (2018) -
Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen
por: Karpenko, Larisa I., et al.
Publicado: (2020) -
Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells
por: Knauer, Nadezhda, et al.
Publicado: (2023) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013) -
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol
por: Kisakov, Denis Nikolaevich, et al.
Publicado: (2022)